N-[(1S)-1-(羟甲基)-2-苯乙基]-乙酰胺 | 52485-51-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-[(1S)-1-(羟甲基)-2-苯乙基]-乙酰胺
• 英文名称: N-((1S)-1-benzyl-2-hydroxyethyl)acetamide
• 英文别名: N-[(1S)-1-benzyl-2-hydroxyethyl]acetamide；(S)-2-N-acetylamido-3-phenyl-1-propanol；(S)-2-acetamido-3-phenylpropan-1-ol；(S)-(-)-Nacetylphenylalaninol；(S)-N-acetylphenylalaninol；N-acetyl-L-phenylalaninol；(S)-N-(1-Hydroxy-3-phenylpropan-2-yl)acetamide；N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]acetamide
• CAS: 52485-51-5
• 化学式: C₁₁H₁₅NO₂
• 分子量: 193.246
• InChiKey: OKDZNDUPIRUYLF-NSHDSACASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335

反应信息

• 作为反应物：
  描述：

  N-[(1S)-1-(羟甲基)-2-苯乙基]-乙酰胺 在 盐酸 、 sodium hydride 作用下， 以 四氢呋喃 、 水 、 mineral oil 为溶剂， 反应 25.0h， 生成 (S)-(+)-α-(甲氧基甲基)苯乙胺 盐酸盐
  参考文献：
  名称：

  The preparation of novel chiral auxiliaries SAMIQ/RAMIQ and their application in the asymmetric Michael addition

  摘要：

  A pair of novel chiral auxiliaries SAMIQ/RAMIQ was synthesized from L- or D-phenylalanine methyl ester hydrochloride over six steps in 45.8% and 44.4% yield, respectively. The SAMIQ-/RAMIQ-hydrazone methodology was applied for the asymmetric Michael addition of ketones to alpha,beta-unsaturated carboxylic acid methyl esters, which afforded 3-substituted-5-oxo-alkanoates in moderate to good yield (65-82%) with excellent enantioselectivity (ee=95.3%similar to>99.5%). (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2014.05.049
• 作为产物：
  描述：

  N-乙酰-L-苯丙氨酸甲酯 在 lithium aluminium tetrahydride 作用下， 以 甲醇 为溶剂， 以94%的产率得到N-[(1S)-1-(羟甲基)-2-苯乙基]-乙酰胺
  参考文献：
  名称：

  Synthesis of enantioenriched 1,2-trans-diamines using the borono-Mannich reaction with N-protected α-amino aldehydes

  摘要：

  Petasis硼-曼尼希三组分反应以易获得的N-保护α-氨基醛为起始物，高效地、对映选择性地产生1,2-反式-二胺，其对映体过量高达98%。

  DOI：

  10.1039/c5cc01716e

文献信息

• Chemokine receptor binding heterocyclic compounds
  申请人：AnorMED, Inc.

  公开号：US06750348B1

  公开（公告）日：2004-06-15

  This invention relates to a novel class of heterocyclic compounds that bind chemokine receptors, inhibiting the binding of their natural ligands thereby. These compounds result in protective effects against infection by HIV through binding to chemokine receptors, including CXCR4 and CCR5, thus inhibiting the subsequent binding by these chemokines. The present invention provides a compound of Formula I wherein, W is a nitrogen atom and Y is absent or, W is a carbon atom and Y═H; R1 to R7 may be the same or different and are independently selected from hydrogen or straight, branched or cyclic C1-6 alkyl; R8 is a substituted heterocyclic group or a substituted aromatic group Ar is an aromatic or heteroaromatic ring each optionally substituted at single or multiple, non-linking positions with electron-donating or withdrawing groups; n and n′ are independently, 0-2; X is a group of the formula: Wherein, Ring A is an optionally substituted, saturated or unsaturated 5 or 6-membered ring, and P is an optionally substituted carbon atom, an optionally substituted nitrogen atom, sulfur or oxygen atom. Ring B is an optionally substituted 5 to 7-membered ring. Ring A and Ring B in the above formula can be connected to the group W from any position via the group V, wherein V is a chemical bond, a (CH2)n″ group (where n″=0-2) or a C═O group. Z is, (1) a hydrogen atom, (2) an optionally substituted C1-6 alkyl group, (3) a C0-6 alkyl group substituted with an optionally substituted aromatic or heterocyclic group, (4) an optionally substituted C0-6 alkylamino or C3-7 cycloalkylamino group, (5) an optionally substituted carbonyl group or sulfonyl. These compounds further include any pharmaceutically acceptable acid addition salts and metal complexes thereof and any stereoisomeric forms and mixtures of stereoisomeric forms thereof.

  这项发明涉及一类新型的杂环化合物，它们结合趋化因子受体，抑制其天然配体的结合。这些化合物通过结合趋化因子受体，包括CXCR4和CCR5，从而抑制这些趋化因子的后续结合，产生对HIV感染的保护效果。本发明提供了一个式I的化合物 其中，W是氮原子，Y不存在，或者W是碳原子，Y═H； R1至R7可以相同也可以不同，并且独立地选择自氢或直链、支链或环状的C1-6烷基； R8是一个取代的杂环基或取代的芳香基 Ar是一个芳香或杂芳环，每个环在单个或多个非连接位置可选择地取代有电子给体或吸引体基团； n和n′独立地为0-2； X是下式的一个基团： 其中，环A是一个可选择地取代的饱和或不饱和的5或6元环，P是一个可选择地取代的碳原子、一个可选择地取代的氮原子、硫或氧原子。环B是一个可选择地取代的5到7元环。上述式中的环A和环B可以通过基团V从任何位置连接到基团W，其中V是一个化学键，一个(CH2)n″基团（其中n″=0-2）或一个C═O基团。Z是(1)一个氢原子，(2)一个可选择地取代的C1-6烷基基团，(3)一个用可选择地取代的芳香或杂环基团取代的C0-6烷基基团，(4)一个可选择地取代的C0-6烷基氨基或C3-7环烷氨基基团，(5)一个可选择地取代的羰基或磺酰基。这些化合物还包括任何药学上可接受的酸盐和金属络合物，以及它们的任何立体异构体形式和立体异构体形式的混合物。
• Method for producing carboxylic acid by alcohol oxidation
  申请人：——

  公开号：US20030045751A1

  公开（公告）日：2003-03-06

  The invention relates to a method for oxidizing primary amino alcohols, primary or secondary alkenols or alkinols into the corresponding acids or ketones. According to said method, a primary amino alcohol or a primary or secondary alkenol or alkinol is oxidized in the form of a substrate, in the presence of an equimolar quantity of periodate or a molar excess thereof in relation to the alcoholic hydroxy groups and catalytic quantities of dichromate or CrO 3 and in the presence of an acid in water, a water/solvent mixture or a solvent at a temperature of −20 ° C. to +50 ° C., to produce the corresponding acid or the corresponding ketone.

  该发明涉及一种将一级氨基醇、一级或二级烯醇或炔醇氧化为相应酸或酮的方法。根据该方法，在存在与醇羟基相对应的等摩尔量的高碘酸盐或其摩尔过量的情况下，将一级氨基醇或一级或二级烯醇或炔醇作为底物氧化，并在水中的酸、水/溶剂混合物或溶剂中，在温度为-20°C至+50°C的条件下，产生相应的酸或相应的酮。
• Isopropenyl acetate, a remarkable, cheap and acylating agent of amines under solvent- and catalyst-free conditions: a systematic investigation
  作者：Romina Pelagalli、Isabella Chiarotto、Marta Feroci、Stefano Vecchio

  DOI：10.1039/c2gc35485c

  日期：——

  Isopropenyl acetate was proved to be an efficient reagent for acetylation of amine in the absence of solvent and catalyst. The corresponding acetamides were obtained in very high yields without any purification.

  在没有溶剂和催化剂的情况下，乙酸异丙烯酯被证明是一种有效的胺乙酰化试剂。无需任何纯化就可以非常高的产率获得相应的乙酰胺。
• An Eco-friendly and Highly Efficient route for N-acylation under Catalyst-free Conditions
  作者：Souad Ouarna、Hacène K’tir、Salah Lakrout、Hamida Ghorab、Aïcha Amira、Zineb Aouf、Malika Berredjem、Nour Aouf

  DOI：10.13005/ojc/310235

  日期：2015.6.20

  An eco-friendly, simple, mild, chemo selective and highly efficient procedure for the acylation of primary and secondary amine function in various structurally and electronically aliphatic and aromatic compounds affording their corresponding N-Ac derivatives is developed. Mild conditions, simplicity and easier work-up are the main advantages of this method.

  开发了一种环保、简单、温和、化学选择性高且高效的方法，用于各种结构和电子性质的脂肪族和芳香族化合物中的伯胺和仲胺官能团的酰化反应，生成相应的N-酰基衍生物。温和条件、简单操作及易于后处理是该方法的主要优点。
• PYRIDINE AND PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS
  申请人：Allen Jennifer R.

  公开号：US20100125062A1

  公开（公告）日：2010-05-20

  Pyridine and pyrimidine compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

  吡啶和嘧啶化合物，以及含有它们的组合物，以及制备这些化合物的方法。本文还提供了治疗通过抑制PDE10可治疗的疾病或疾病的方法，如肥胖症、非胰岛素依赖型糖尿病、精神分裂症、躁郁症、强迫症等。